These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 29044636
1. An inverse association between serum resistin levels and n-3 polyunsaturated fatty acids intake was strongest in the SNP-420 G/G genotype in the Japanese cohort: The Toon Genome Study. Noumi Y, Kawamura R, Tabara Y, Maruyama K, Takata Y, Nishida W, Okamoto A, Nishimiya T, Onuma H, Saito I, Tanigawa T, Osawa H. Clin Endocrinol (Oxf); 2018 Jan; 88(1):51-57. PubMed ID: 29044636 [Abstract] [Full Text] [Related]
2. A at single nucleotide polymorphism-358 is required for G at -420 to confer the highest plasma resistin in the general Japanese population. Onuma H, Tabara Y, Kawamura R, Tanaka T, Ohashi J, Nishida W, Takata Y, Ochi M, Yamada K, Kawamoto R, Kohara K, Miki T, Makino H, Osawa H. PLoS One; 2010 Mar 16; 5(3):e9718. PubMed ID: 20300528 [Abstract] [Full Text] [Related]
3. PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population. Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Miki T, Makino H, Kohara K. Clin Endocrinol (Oxf); 2009 Sep 16; 71(3):341-5. PubMed ID: 19178525 [Abstract] [Full Text] [Related]
6. Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Kohara K, Miki T, Makino H. Diabetes Care; 2007 Jun 16; 30(6):1501-6. PubMed ID: 17384338 [Abstract] [Full Text] [Related]
8. Ratios of serum eicosapentaenoic acid to arachidonic acid and docosahexaenoic acid to arachidonic acid were inversely associated with serum resistin levels: The Hisayama Study. Higashioka M, Hirakawa Y, Kawamura R, Honda T, Hata J, Yoshida D, Takata Y, Kitazono T, Osawa H, Ninomiya T. J Diabetes Investig; 2020 Mar 16; 11(2):482-489. PubMed ID: 31433904 [Abstract] [Full Text] [Related]
9. Fish, n - 3 polyunsaturated fatty acids and n - 6 polyunsaturated fatty acids intake and breast cancer risk: The Japan Public Health Center-based prospective study. Kiyabu GY, Inoue M, Saito E, Abe SK, Sawada N, Ishihara J, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Shibuya K, Tsugane S, JPHC Study Group. Int J Cancer; 2015 Dec 15; 137(12):2915-26. PubMed ID: 26147326 [Abstract] [Full Text] [Related]
11. Genome-wide association study of plasma resistin levels identified rs1423096 and rs10401670 as possible functional variants in the Japanese population. Kawamura R, Tabara Y, Tsukada A, Igase M, Ohashi J, Yamada R, Takata Y, Kawamoto R, Saito I, Onuma H, Tanigawa T, Yamada K, Kato N, Ohyagi Y, Miki T, Kohara K, Osawa H. Physiol Genomics; 2016 Nov 01; 48(11):874-881. PubMed ID: 27664181 [Abstract] [Full Text] [Related]
12. Plasma resistin is associated with single nucleotide polymorphisms of a possible resistin receptor, the decorin gene, in the general Japanese population. Onuma H, Tabara Y, Kawamura R, Ohashi J, Nishida W, Takata Y, Ochi M, Nishimiya T, Kawamoto R, Kohara K, Miki T, Osawa H. Diabetes; 2013 Feb 01; 62(2):649-52. PubMed ID: 23193185 [Abstract] [Full Text] [Related]
17. Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Ukkola O, Kunnari A, Kesäniemi YA. Regul Pept; 2008 Aug 07; 149(1-3):56-9. PubMed ID: 18440081 [Abstract] [Full Text] [Related]
18. Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Tsukahara T, Nakashima E, Watarai A, Hamada Y, Naruse K, Kamiya H, Nakamura N, Kato N, Hamajima N, Sekido Y, Niwa T, Tomita M, Oiso Y, Nakamura J. Diabetes Res Clin Pract; 2009 May 07; 84(2):179-86. PubMed ID: 19269054 [Abstract] [Full Text] [Related]
19. Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Osawa H, Onuma H, Ochi M, Murakami A, Yamauchi J, Takasuka T, Tanabe F, Shimizu I, Kato K, Nishida W, Yamada K, Tabara Y, Yasukawa M, Fujii Y, Ohashi J, Miki T, Makino H. Biochem Biophys Res Commun; 2005 Sep 23; 335(2):596-602. PubMed ID: 16087164 [Abstract] [Full Text] [Related]
20. Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes. Ochi M, Osawa H, Hirota Y, Hara K, Tabara Y, Tokuyama Y, Shimizu I, Kanatsuka A, Fujii Y, Ohashi J, Miki T, Nakamura N, Kadowaki T, Itakura M, Kasuga M, Makino H. Diabetes; 2007 Nov 23; 56(11):2834-8. PubMed ID: 17698599 [Abstract] [Full Text] [Related] Page: [Next] [New Search]